{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:43:13Z","timestamp":1791852193111,"version":"4.3.4"},"reference-count":48,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/006-05"],"award-info":[{"award-number":["503\/006-05"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>(1) Background: L-tryptophan is a substrate for the synthesis of many biological compounds through the serotonin and kynurenine pathways. These compounds have a significant influence on gastrointestinal functions and mental processes. The aim of the study was to evaluate the urinary excretion of selected tryptophan metabolites in patients with constipation-predominant and diarrhoea-predominant irritable bowel syndrome (IBS-C and IBS-D, respectively), related to somatic and mental symptoms. (2) Methods: 120 people were included in the study and three groups were distinguished, with 40 individuals each, including healthy subjects (controls), patients with IBS-C and patients with IBS-D. The Gastrointestinal Symptoms Rating Scale (GSRS-IBS) was used to assess the severity of abdominal symptoms. The Hamilton Anxiety Rating Scale (HAM-A) and Hamilton Depression Rating Scale (HAM-D) were used to evaluate the mental state of patients. Using liquid chromatography tandem mass spectrometry (LC-MS\/MS), L-tryptophan and the following metabolites in urine, related to the creatinine level, were measured: 5-hydroxyindoleacetic acid (5-HIAA), kynurenine (KYN), kynurenic acid (KYNA) and quinolinic acid (QA). (3) Results: In both groups of patients with IBS, changes in tryptophan metabolism were found as compared to the control group. We observed an increase in the activity of the serotonin pathway and a positive correlation between the 5-HIAA level and the GSRS score (p &lt; 0.01) and HAM-A score (p &lt; 0.001) in IBS-D patients. The IBS-C group was characterized by a higher concentration of kynurenines (KYN, QA) in urine. Moreover, the QA (p &lt; 0.001) and KYNA (p &lt; 0.05) levels were correlated with the HAM-D score among IBS-C patients. (4) Conclusions: Various changes in the tryptophan metabolism pathway can determine the differences in the clinical picture of irritable bowel syndrome. These results should be included in the nutritional and pharmacological treatment of this syndrome.<\/jats:p>","DOI":"10.3390\/nu15051262","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T01:43:00Z","timestamp":1677807780000},"page":"1262","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Changes in Tryptophan Metabolism on Serotonin and Kynurenine Pathways in Patients with Irritable Bowel Syndrome"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-4775","authenticated-orcid":false,"given":"Cezary","family":"Chojnacki","sequence":"first","affiliation":[{"name":"Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"B\u0142o\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Konrad","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Chojnacki","sequence":"additional","affiliation":[{"name":"Department of Clinical Nutrition and Gastroenterological Diagnostics, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Podogrocki","sequence":"additional","affiliation":[{"name":"Biohazard Prevention Centre, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2300-7339","authenticated-orcid":false,"given":"Tomasz","family":"Poplawski","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Microbiology and Biochemistry, Medical University of Lodz, 92-216 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lacy, B.E., and Patel, N.K. (2017). Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J. Clin. Med., 6.","DOI":"10.3390\/jcm6110099"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bassotti, G. (2022). Irritable Bowel Syndrome: A Multifaceted World Still to Discover. J. Clin. Med., 11.","DOI":"10.3390\/jcm11144103"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000503757","article-title":"Irritable Bowel Syndrome: News from an Old Disorders","volume":"27","author":"Ferreira","year":"2020","journal-title":"GE Port. J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gros, M., Gros, B., Mesonero, J.E., and Latorre, E. (2021). Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management. J. Clin. Med., 10.","DOI":"10.3390\/jcm10153429"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Guzel, T., and Mirowska-Guzel, D. (2022). The Role of serotonin Neurotransmission in Gastrointestinal Tract. Molecules, 27.","DOI":"10.3390\/molecules27051680"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jenkins, T.A., Nguyen, J.C.D., Polglaze, K.E., and Bertrand, P.P. (2016). Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis. Nutrients, 8.","DOI":"10.3390\/nu8010056"},{"key":"ref_8","first-page":"1178646917691938","article-title":"Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects","volume":"15","author":"Badawy","year":"2017","journal-title":"Int. J. Trypt. Res. IJTR"},{"key":"ref_9","first-page":"8952520","article-title":"Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in Humans","volume":"2016","author":"Palego","year":"2016","journal-title":"J. Am. Acids"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000068","article-title":"Tryptophan Metabolism in the Central Nervous System: Medical Implications","volume":"8","author":"Ruddick","year":"2006","journal-title":"Exp. Rev. Mol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons","volume":"16","author":"Braidy","year":"2009","journal-title":"Neurotox. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/pcn.12944","article-title":"Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case control study","volume":"74","author":"Colle","year":"2020","journal-title":"Psych. Clin. Neurosc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neubiorev.2018.05.031","article-title":"Role of Kynurenine Pathway and Its Metabolites in Mood Disorders: A Systematic Review and Meta-Analysis of Clinical Studies","volume":"92","author":"Arnone","year":"2018","journal-title":"Neurosc. Biobeh. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/10253890701754068","article-title":"A Link between Stress and Depression: Shifts in the Balance between the Kynurenine and Serotonin Pathways of Tryptophan Metabolism and the Etiology and Pathophysiology of Depression","volume":"11","author":"Miura","year":"2008","journal-title":"Stress"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2006.02858.x","article-title":"Review article: Intestinal serotonin signalling in irritable bowel syndrome","volume":"23","author":"Mawe","year":"2006","journal-title":"Alimen. Pharm. Therap."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cca.2009.01.028","article-title":"Role of serotonin in gastrointestinal motility and irritable bowel syndrome","volume":"403","author":"Sikander","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signalling system: From basic understanding to drug development for functional GI disorders","volume":"132","author":"Gerson","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1111\/j.1572-0241.2000.03177.x","article-title":"Serotonin: A mediator of the brain-gut connection","volume":"95","author":"Kim","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.nutres.2010.09.009","article-title":"Increased Serum Free Tryptophan in Patients with Diarrhea-Predominant Irritable Bowel Syndrome","volume":"30","author":"Christmas","year":"2010","journal-title":"Nutr. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fpsyt.2020.00664","article-title":"Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome\u2013An Update","volume":"11","author":"Takakura","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/2050640619900577","article-title":"Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study","volume":"8","author":"Ljotsson","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000506879","article-title":"The Hamilton Rating Scales for Depression: A Critical Review of Clinimetric Properties of Different Versions","volume":"89","author":"Carrozzino","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/gut.42.1.42","article-title":"Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome","volume":"42","author":"Beacroft","year":"1998","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2982.2007.00943.x","article-title":"Sigmoid-colonic motility in healthy and irritable bowel syndrome: A role for 5-hydroxytryptamine","volume":"19","author":"Houghton","year":"2007","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_25","first-page":"366","article-title":"Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome","volume":"22","author":"Moskwa","year":"2007","journal-title":"Pol. Merkur. Lek."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","article-title":"Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome","volume":"3","author":"Dunlop","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","article-title":"Altered 5- hydroxytryptamine signalling in patients with constipation- and diarrhoea irritable bowel syndrome","volume":"130","author":"Atkinson","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2982.2007.00965.x","article-title":"Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: Alteration in 5-HT signalling and metabolism in human disease","volume":"19","author":"Spiller","year":"2007","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3892\/mmr.2013.1325","article-title":"Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome","volume":"7","author":"Wendelbo","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","article-title":"Molecular defects in mucosal serotonin and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome","volume":"126","author":"Coates","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000051888","article-title":"Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhoea-predominant patients and subjects with normal bowel habits","volume":"53","author":"Miwa","year":"2001","journal-title":"Digestion"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.3748\/wjg.v22.i12.3451","article-title":"Comparison of 5-hydroxytryptophan signalling pathway characteristics in diarrhoea-predominant irritable bowel syndrome and ulcerative colitis","volume":"22","author":"Yu","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_33","first-page":"711","article-title":"Evaluation of serotonin and dopamine secretion and metabolism in patients with irritable bowel syndrome","volume":"128","author":"Chojnacki","year":"2018","journal-title":"Pol. Arch. Int. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Chojnacki, C., Pop\u0142awski, T., Gasiorowska, A., Chojnacki, J., and Blasiak, J. (2021). Serotonin in the Pathogenesis of Lymphocytic Colitis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10020285"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/apt.13459","article-title":"Alterations in serotonin metabolism in irritable bowel syndrome","volume":"43","author":"Thijssen","year":"2016","journal-title":"Aliment. Pharm. Therap."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Clarke, G., Fitzgerald, P., Cryan, J.F., Cassidy, E.M., Quigley, E.M., and Dinan, T.G. (2009). Tryptophan Degradation in Irritable Bowel Syndrome: Evidence of Indoleamine 2,3-Dioxygenase Activation in a Male Cohort. BMC Gastroenterol., 9.","DOI":"10.1186\/1471-230X-9-6"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1099800415594251","article-title":"Serum Tryptophan Metabolite Levels During Sleep in Patients With and Without Irritable Bowel Syndrome (IBS)","volume":"18","author":"Heitkemper","year":"2015","journal-title":"Biol. Res. Nurs."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jpsychores.2013.01.008","article-title":"Decreased Levels of Kynurenic Acid in the Intestinal Mucosa of IBS Patients: Relation to Serotonin and Psychological State","volume":"74","author":"Keszthelyi","year":"2013","journal-title":"J. Psychosom. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1365-2982.2008.01195.x","article-title":"Tryptophan Catabolism in Females with Irritable Bowel Syndrome: Relationship to Interferon-Gamma, Severity of Symptoms and Psychiatric Co-Morbidity","volume":"20","author":"Fitzgerald","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chojnacki, C., Konrad, P., B\u0142o\u0144ska, A., M\u0119drek-Socha, M., Przyby\u0142owska-Sygut, K., Chojnacki, J., and Pop\u0142awski, T. (2022). Altered Tryptophan Metabolism on the Kynurenine Pathway I Depressive Patients with Small Intestinal Bacterial Overgrowth. Nutrients, 14.","DOI":"10.3390\/nu14153217"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.pain.2013.09.008","article-title":"Stress and visceral pain: Focusing on irritable bowel syndrome","volume":"154","author":"Fakudo","year":"2013","journal-title":"Pain"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Aziz, M.N.M., Kumar, J., Nawawi, K.N.M., Ali, R.A.R., and Mohtar, N.M. (2021). Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain. Nutrients, 13.","DOI":"10.3390\/nu13093061"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1038\/s41598-021-81654-1","article-title":"Diet and companionship modulate pain via a serotonergic mechanism","volume":"11","author":"Tran","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/flgastro-2019-101298","article-title":"Best management of irritable bowel syndrome","volume":"12","author":"Black","year":"2021","journal-title":"Frontline Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","article-title":"Serotonin, tryptophan metabolism and brain-gut-microbiome axis","volume":"277","author":"Clarke","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","article-title":"Neurotransmitters modulation by the gut microbiota","volume":"163","author":"Strandwitz","year":"2018","journal-title":"Brain Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"841703","DOI":"10.3389\/fendo.2022.841703","article-title":"The Mechanism Underlying the Influence of Indole-3-Propionic Acid: A Relevance to Metabolic Disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.4102","article-title":"CARD9 Impacts Colitis by Altering Gut Microbiota Metabolism of Tryptophan into Aryl Hydrocarbon Receptor Ligands","volume":"22","author":"Lamas","year":"2016","journal-title":"Nat. Med."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/5\/1262\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:46:43Z","timestamp":1760122003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/5\/1262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["nu15051262"],"URL":"https:\/\/doi.org\/10.3390\/nu15051262","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]}}}